FDA warns of serious genital infection with SGLT2 Inhibitors
The U.S. Food and Drug Administration (FDA) released a statement that a serious genital infection has been reported in patients taking a certain class of diabetes drugs, with one death and 11 others hospitalized.

The warning pertains to a class of medicines called SGLT2 inhibitors, first approved in 2013 to lower blood sugar in adults with type 2 diabetes. FDA has also called for including this risk in the drugs’ labeling.

Patients are at risk of the infection known as Fournier’s gangrene, an extremely rare but life-threatening bacterial infection of the tissue under the skin that surrounds the genital area, the FDA said in a statement.

The bacteria usually enter the body through a cut and quickly spread. Having diabetes is a risk factor for developing Fournier’s gangrene. The FDA said it identified 12 cases of Fournier’s gangrene - 7 in men and 5 in women - between March 2013 and May 2018.

More here: https://in.reuters.com/article/us-diabetesdrugs-fda/fda-warns-of-serious-genital-infection-linked-to-certain-diabetes-drugs-idINKCN1LE2PQ
Dr. D●v D●●●●n and 2 other likes this3 shares
Like
Comment
Share